Viagra and The Pharmaceutical Industry: A Volatile Investment?

The trajectory of Sildenafil presents a complex picture for shareholders. While the initial introduction generated massive gains, the lapse of its exclusive rights opened the floodgates to off-brand versions, dramatically eroding revenue. This creates a specific risk for pharmaceutical companies depending on comparable blockbuster medications, sugg

read more

Elite Gambler's Sildenafil: A Risky Gamble

The emergence of so-called "Elite Roller The Pill" – often referring to exceptionally high doses prescribed by disreputable physicians – represents a troublingly alarming trend. While typical dosages of Viagra are intended for treating erectile dysfunction safely in most patients, these significantly elevated quantities pose a grave risk to car

read more